Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MicroRNA pioneers win Nobel Prize for medicine
Pharmaphorum
Monday, October 7, 2024 - 11:21am
tags:
Nobel Prize, microRNAQ, genetics
Judo Bio debuts with $100M and a plan to take RNA drugs to the kidney
BioPharma Dive
Monday, October 7, 2024 - 11:18am
tags:
Jude Bio, RNA, ligand-siRNA, funding
For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's been
Fierce Pharma
Monday, October 7, 2024 - 11:16am
tags:
Bristol Myers Squibb, KarXT, Cobenfy, schizophrenia
Alnylam agrees to drop patent lawsuit against Moderna over Covid-19 vaccine
Reuters
Sunday, October 6, 2024 - 10:50pm
tags:
Alnylam, Moderna Therapeutics, legal, patents, vaccines
Trump backs off proposal to slash prescription drug prices by linking them to foreign countries
Stat
Sunday, October 6, 2024 - 10:46pm
tags:
2024 Presidential election, Donald Trump, drug pricing.
Abbott & Edwards Square Off in Tricuspid Repair
Medical Devices and Diagnostics Industry
Sunday, October 6, 2024 - 10:43pm
tags:
Medtech, Abbott Labs, Edwards, CMS, TriClip, tricuspid valve disease
[podcast]Breaking down BIOSECURE—Industry implications and what comes next
Fierce Pharma
Friday, October 4, 2024 - 11:02am
tags:
Biosecure Act, legislation
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports
Reuters
Friday, October 4, 2024 - 9:41am
tags:
GSK, Sanofi, CSL, vaccines, bird flu
Ultragenyx tweaks gene therapy dosing to dial up efficacy after seeing signs of activity
Fierce Biotech
Friday, October 4, 2024 - 9:38am
tags:
Ultragenyx Pharmaceutical, Wilson disease, gene therapy, UX701
Teva and mAbxience partner to develop biosimilar candidate for oncology
Pharmaceutical Technology
Friday, October 4, 2024 - 9:28am
tags:
Teva Pharmaceutical, mAbxience, oncology, biosimilars
FDA grants priority review for AstraZeneca’s Calquence sNDA
Pharmaceutical Business Review
Friday, October 4, 2024 - 9:26am
tags:
AstraZeneca, Calquence, FDA, priority review
BD Moves to Settle the Majority of Its Hernia Mesh Litigation
Medical Devices and Diagnostics Industry
Friday, October 4, 2024 - 9:25am
tags:
Becton Dickinson, legal, hernia mesh, Medtech
Editas cashes in on portion of Vertex gene editing licensing agreement for $57M
Fierce Biotech
Friday, October 4, 2024 - 9:24am
tags:
Editas Medicine, Cas9, patents, Vertex Pharmaceuticals, gene editing
Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show
Reuters
Friday, October 4, 2024 - 9:22am
tags:
Thermo Fisher, FDA, RSV, Beyfortus, Sanofi, AstraZeneca, drug manufacturing
An Alzheimer’s drugmaker is accused of data ‘manipulation.’ Should its trials be stopped?
Pharma Voice
Friday, October 4, 2024 - 9:19am
tags:
Cassava Sciences, Alzheimer's disease, data manipulation
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Pharmaphorum
Friday, October 4, 2024 - 9:18am
tags:
Boehringer Ingelheim, Veeva, One Medicine Platform, Clinical Data
Sanofi Offloads Rare Autoimmune Drug to Recordati in Potential $1B Deal
BioSpace
Friday, October 4, 2024 - 9:17am
tags:
Sanofi, Recordati, autoimmune disease, cold agglutinin disease
BMS' Opdivo joins the perioperative lung cancer treatment ring with key FDA approval
Fierce Pharma
Thursday, October 3, 2024 - 10:25pm
tags:
Bristol Myers Squibb, Opdivo, FDA, non-small cell lung cancer
AbbVie cuts 2024 profit forecast citing R&D expenses
Reuters
Thursday, October 3, 2024 - 9:26pm
tags:
AbbVie, R&D
Relay cuts more staff in efforts to save $50M a year
Fierce Biotech
Thursday, October 3, 2024 - 9:25pm
tags:
Relay Therapeutics, precision medicine, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.